Ecuador vs Laos: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Laos
100.0%
in 2024
Ecuador rank
1st
Laos rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Laos
How they compare
Ecuador currently reports 100.0% against 100.0% in Laos, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2012 it was Ecuador ahead.
Ecuador ranks 1st and Laos ranks 1st of 192 countries.
Laos has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.2% | 40.1% | 18.8% | Laos |
| 2020s | 95.8% | 97.8% | 2.0% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Laos?
- Ecuador, at 100.0% against 100.0% in Laos as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Laos?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Laos?
- 11 years are reported by both, from 2012 to 2024.
- How do Ecuador and Laos rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Laos ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.